Published in Thromb Res on June 01, 1988
Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I. Biochim Biophys Acta (1986) 1.53
Distribution of type I, III, IV and V collagen in normal and atherosclerotic human arterial wall: immunomorphological characteristics. Coll Relat Res (1985) 1.29
Morphological alterations in endothelial cells from human aorta and umbilical vein induced by forskolin and phorbol 12-myristate 13-acetate: a synergistic action of adenylate cyclase and protein kinase C activators. Proc Natl Acad Sci U S A (1986) 1.17
Rapid blood clearance of biotinylated IgG after infusion of avidin. J Nucl Med (1989) 1.15
Inhibition of platelet behaviour by feverfew: a mechanism of action involving sulphydryl groups. Folia Haematol Int Mag Klin Morphol Blutforsch (1988) 1.14
Relative distribution of fibronectin and type I, III, IV, V collagens in normal and atherosclerotic intima of human arteries. Atherosclerosis (1987) 1.10
Retrospective reconstruction of individual and collective external gamma doses of population evacuated after the Chernobyl accident. Health Phys (1994) 1.09
Dimer state of protein L7/L12 and EF-G-dependent reactions of ribosomes. Eur J Biochem (1978) 1.05
Nitric oxide inhibits proliferation of human endothelial cells via a mechanism independent of cGMP. Atherosclerosis (1999) 1.04
Flow cytometric determination of E-selectin, vascular cell adhesion molecule-1, and intercellular cell adhesion molecule-1 in formaldehyde-fixed endothelial cell monolayers. Cytometry (2000) 1.04
The role of red cell membrane in the regulation of glycolysis and the 2,3-bisphosphoglycerate-cycle. Acta Biol Med Ger (1977) 1.04
Primary culture of endothelial cells from atherosclerotic human aorta. Part 1. Identification, morphological and ultrastructural characteristics of two endothelial cell subpopulations. Atherosclerosis (1986) 1.04
L-Ascorbic acid potentiates nitric oxide synthesis in endothelial cells. J Biol Chem (1999) 1.02
Cell proliferation in normal and atherosclerotic human aorta. I. Flow cytofluorometric determination of cellular deoxyribonucleic acid content. Lab Invest (1983) 1.00
Procoagulant activity in patients with isolated severe head trauma. Crit Care Med (1998) 0.99
Heterogeneity of endothelium in human aorta. A quantitative analysis by scanning electron microscopy. Atherosclerosis (1984) 0.96
Endothelial cell culture on fibrillar collagen: model to study platelet adhesion and liposome targeting to intercellular collagen matrix. Proc Natl Acad Sci U S A (1981) 0.96
Stromal differentiation and architecture of the human umbilical cord. Placenta (1997) 0.95
GPIIb-IIIa antagonists cause rapid disaggregation of platelets pre-treated with cytochalasin D. Evidence that the stability of platelet aggregates depends on normal cytoskeletal assembly. Platelets (1998) 0.95
Flow-cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actin status of activated platelets. Cytometry (1990) 0.95
Human platelet electrorotation change induced by activation: inducer specificity and correlation to serotonin release. Biochim Biophys Acta (1988) 0.92
[Isolation of highly purified phosphoglycerate kinase from rabbit skeletal muscles]. Biokhimiia (1967) 0.92
Elongation factor-dependent reactions of ribosomes deprived of proteins L7 and L12. FEBS Lett (1977) 0.92
Cell proliferation in normal and atherosclerotic human aorta. II. Autoradiographic observation on deoxyribonucleic acid synthesis in primary cell culture. Lab Invest (1983) 0.90
Participance of fibronectin and various collagen types in the formation of fibrous extracellular matrix in cardiosclerosis. J Mol Cell Cardiol (1988) 0.90
Protein kinase C and cyclic AMP modulate thrombin-induced platelet-activating factor synthesis in human endothelial cells. Biochim Biophys Acta (1991) 0.90
Determination of specific radioactivities of mononucleotides and glycolytic intermediates from mouse liver after labelling in vivo with [32P]orthophosphate. Eur J Biochem (1968) 0.89
Enzymic flux rates in vivo through the Embden-Meyerhof pathway and the nucleotides of the mouse liver. Eur J Biochem (1968) 0.88
Catecholamine-mediated injury to endothelium in rabbit perfused aorta: a quantitative analysis by scanning electron microscopy. Cor Vasa (1985) 0.87
Hemolytic complement activity assay in microtitration plates. J Appl Biochem (1985) 0.86
Advanced neuronavigation in skull base tumors and vascular lesions. Minim Invasive Neurosurg (2005) 0.86
Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall. Proc Natl Acad Sci U S A (1986) 0.86
Analysis of the effectiveness of emergency countermeasures in the 30-km zone during the early phase of the Chernobyl accident. Health Phys (1994) 0.86
Red blood cell targeting to collagen-coated surfaces. FEBS Lett (1983) 0.85
Dibutyryl cyclic AMP decreases proliferative activity and the cholesteryl ester content in cultured cells of atherosclerotic human aorta. Biochem Biophys Res Commun (1982) 0.85
Isolated cells in suspension for biological research--Part III. Structure and functional properties of enterocytes and adipocytes. Exp Pathol (1988) 0.85
Targeting of enzyme immobilized on erythrocyte membrane to collagen-coated surface. FEBS Lett (1985) 0.85
Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups. J Pharm Pharmacol (1987) 0.85
Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction. Thromb Res (1991) 0.84
Intimal cells and atherosclerosis. Relationship between the number of intimal cells and major manifestations of atherosclerosis in the human aorta. Am J Pathol (1986) 0.84
Study of low density lipoprotein interaction with platelets by flow cytofluorimetry. FEBS Lett (1982) 0.84
Flow cytofluorometric study of lipoprotein interactions with cultured endothelial cells. Cytometry (1982) 0.84
High-affinity association and degradation of 125I-labelled low density lipoproteins by human hepatocytes in primary culture. FEBS Lett (1985) 0.84
Enzyme immunoassay of the receptors for modified low density lipoprotein. Anal Biochem (1986) 0.84
Inhibition of cholesterol synthesis by lovastatin tested on six human cell types in vitro. Lipids (1990) 0.83
Type I and III collagens as a possible target for drug delivery to the injured sites of vascular bed. Biochem Biophys Res Commun (1983) 0.83
Aortic endothelium of alloxan diabetic rabbits: a quantitative study using scanning electron microscopy. Diabetologia (1982) 0.83
Effect of metabolic inhibitors on platelet attachment, spreading and aggregation on collagen-coated surfaces. Thromb Res (1987) 0.83
Estimation of 131I thyroid doses for the evacuees from Pripjat. Radiat Environ Biophys (1996) 0.82
VLDL apoprotein secretion and apo-B mRNA level in primary culture of cholesterol-loaded rabbit hepatocytes. FEBS Lett (1988) 0.82
Identification of intimal subendothelial cells from human aorta in primary culture. Atherosclerosis (1988) 0.82
Relations between ion shifting, ATP depletion and lactic acid formation in human red cells during moderate calcium loading using the ionophore A 23187. Acta Biol Med Ger (1977) 0.82
The role of lipoproteins in the degradation of platelet-activating factor. Thromb Res (1986) 0.82
Directed targeting of immunoerythrocytes provides local protection of endothelial cells from damage by hydrogen peroxide. Am J Pathol (1987) 0.82
Comparison of different lasers in terms of thrombogenicity of the laser-treated vascular wall. Lasers Surg Med (1988) 0.82
Differences in morphology and protein pattern of human blood platelets during irreversible and diamide mediated reversible aggregation. Biomed Biochim Acta (1983) 0.82
A 90-kd surface antigen from a subpopulation of smooth muscle cells from human atherosclerotic lesions. Am J Pathol (1989) 0.82
Human endothelial cells are target for platelet-activating factor. II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells. J Immunol (1992) 0.82
The effect of rapid thoracoabdominal compressions on intracranial pressure in newborn lambs. Pediatr Res (1995) 0.82
Effect of cell cholesterol content on apolipoprotein B secretion and LDL receptor activity in the human hepatoma cell line, HepG2. Biochim Biophys Acta (1989) 0.81
Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor. Thromb Res (1983) 0.81
Methylene blue inhibits the arachidonic acid metabolism in human blood platelets. Biomed Biochim Acta (1988) 0.81
RNA-binding activity of eukaryotic initiation factors of translation. FEBS Lett (1980) 0.81
Both apolipoproteins B-48 and B-100 are synthesized and secreted by the human intestine. J Lipid Res (1990) 0.81
Changes in the distribution and organization of platelet actin induced by diamide and its functional consequences. Br J Haematol (1987) 0.81
Penetration of macromolecules into contracted blood clot. Biophys J (1992) 0.81
Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis. Folia Haematol Int Mag Klin Morphol Blutforsch (1988) 0.80
Effect of flow rate and blood cellular elements on the efficiency of red blood cell targeting to collagen-coated surfaces. J Appl Biochem (1984) 0.80
Inhibition of cholesterol synthesis and esterification regulates high density lipoprotein interaction with isolated epithelial cells of human small intestine. J Lipid Res (1990) 0.80
Fibrillar, fibril-associated and basement membrane collagens of the arterial wall: architecture, elasticity and remodeling under stress. Curr Pharm Des (2015) 0.80
Human plasma fibronectin promotes the adhesion and spreading of platelets on surfaces coated with fibrillar collagen. FEBS Lett (1981) 0.80
Enzyme-linked immunoreceptor assay of low-density-lipoprotein receptors. Anal Biochem (1985) 0.80
Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor. Thromb Res (1987) 0.80
Postnatal development of hepatocellular apolipoprotein B assembly and secretion in the rat. J Lipid Res (2001) 0.80
[Distribution of myosin in a primary culture of human aortic intimal cells]. Biull Eksp Biol Med (1984) 0.79
An extract of feverfew inhibits interactions of human platelets with collagen substrates. Thromb Res (1987) 0.79
Effect of compounds causing reversible perturbation of the cellular thiol-disulfide status on the aggregation of human blood platelets. Biomed Biochim Acta (1983) 0.79
Platelet membrane defects in fawn hooded bleeder rats. Thromb Res (1990) 0.79
Role of glutathione in platelet function. Folia Haematol Int Mag Klin Morphol Blutforsch (1988) 0.79
Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets. Thromb Res (1984) 0.79
Interconversions of HDL subfractions in normolipidemic and hypoalphacholesterolemic sera incubated with fibroblasts and hepatoma cell line Hep-G2. Biochem Int (1988) 0.79
Role of GPIIb-IIIa in platelet-monocyte and platelet-neutrophil conjugate formation in whole blood. Platelets (1998) 0.79
Binding of partially reassembled high-density lipoprotein to isolated human small intestine epithelial cells. Effect of lipid composition. Biochim Biophys Acta (1988) 0.79
Cholesterol can stimulate secretion of apolipoprotein B by cultured human hepatocytes. Biochim Biophys Acta (1985) 0.79
Adult human aortic cells in primary culture: heterogeneity in shape. Heart Vessels (1986) 0.79
Activation of endothelial guanylate cyclase inhibits cellular reactivity. Agents Actions Suppl (1995) 0.78
Step-by-step analysis of adhesion of human platelets to a collagen-coated surface defect in initial attachment and spreading of platelets in von Willebrand's disease. Thromb Res (1984) 0.78
Localization of phosphatidylethanolamine in the plasma membrane of diamide-treated human blood platelets. Biomed Biochim Acta (1985) 0.78
Net mass transfer of plasma cholesteryl esters and lipid transfer proteins in normolipidemic patients with peripheral vascular disease. Metabolism (1999) 0.78
Effect of bezafibrate on lipoprotein secretion by cultured human hepatocytes. Atherosclerosis (1987) 0.78
Purification and characterization of commercial NADH and accompanying dehydrogenase inhibitors. J Chromatogr (1976) 0.78
Compartmentation of orthophosphate and adenine nucleotides in human red cells. Eur J Biochem (1973) 0.78
Helenalin and 11 alpha,13-dihydrohelenalin, two constituents from Arnica montana L., inhibit human platelet function via thiol-dependent pathways. Thromb Res (1990) 0.78
Artificial HDL as an anti-atherosclerotic drug. Lancet (1984) 0.78
Rapid and complete separation of red cells from 32 P-orthophosphate containing medium. Acta Biol Med Ger (1972) 0.78